231 related articles for article (PubMed ID: 17118664)
1. N-Phenyl-N'-(2-chloroethyl)ureas (CEU) as potential antineoplastic agents. Part 2: role of omega-hydroxyl group in the covalent binding to beta-tubulin.
Fortin S; Moreau E; Patenaude A; Desjardins M; Lacroix J; Rousseau JL; C-Gaudreault R
Bioorg Med Chem; 2007 Feb; 15(3):1430-8. PubMed ID: 17118664
[TBL] [Abstract][Full Text] [Related]
2. N-Phenyl-N'-(2-chloroethyl)ureas (CEUs) as potential antineoplastic agents. Part 3: role of carbonyl groups in the covalent binding to the colchicine-binding site.
Moreau E; Fortin S; Lacroix J; Patenaude A; Rousseau JL; C-Gaudreault R
Bioorg Med Chem; 2008 Feb; 16(3):1206-17. PubMed ID: 17998163
[TBL] [Abstract][Full Text] [Related]
3. Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site.
Fortin JS; Lacroix J; Desjardins M; Patenaude A; Petitclerc E; C-Gaudreault R
Bioorg Med Chem; 2007 Jul; 15(13):4456-69. PubMed ID: 17498960
[TBL] [Abstract][Full Text] [Related]
4. Optimized N-phenyl-N'-(2-chloroethyl)ureas as potential antineoplastic agents: synthesis and growth inhibition activity.
Moreau E; Fortin S; Desjardins M; Rousseau JL; Petitclerc E; C-Gaudreault R
Bioorg Med Chem; 2005 Dec; 13(24):6703-12. PubMed ID: 16165366
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of N-phenyl-N'-(2-chloroethyl)ureas in the colchicine-binding site at the interface between alpha- and beta-tubulin.
Fortin S; Wei L; Moreau E; Labrie P; Petitclerc E; Kotra LP; C-Gaudreault R
Bioorg Med Chem; 2009 May; 17(10):3690-7. PubMed ID: 19398206
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the covalent binding of N-phenyl-N'-(2-chloroethyl)ureas to {beta}-tubulin: importance of Glu198 in microtubule stability.
Fortin S; Bouchon B; Chambon C; Lacroix J; Moreau E; Chezal JM; Degoul F; C-Gaudreault R
J Pharmacol Exp Ther; 2011 Feb; 336(2):460-7. PubMed ID: 20978170
[TBL] [Abstract][Full Text] [Related]
7. N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety?
Fortin S; Moreau E; Lacroix J; Teulade JC; Patenaude A; C-Gaudreault R
Bioorg Med Chem Lett; 2007 Apr; 17(7):2000-4. PubMed ID: 17291753
[TBL] [Abstract][Full Text] [Related]
8. A comparative molecular field and comparative molecular similarity indices analyses (CoMFA and CoMSIA) of N-phenyl-N'-(2-chloroethyl)ureas targeting the colchicine-binding site as anticancer agents.
Fortin S; Labrie P; Moreau E; Wei L; Kotra LP; C-Gaudreault R
Bioorg Med Chem; 2008 Feb; 16(4):1914-26. PubMed ID: 18023585
[TBL] [Abstract][Full Text] [Related]
9. Intramolecular cyclization of N-phenyl N'(2-chloroethyl)ureas leads to active N-phenyl-4,5-dihydrooxazol-2-amines alkylating β-tubulin Glu198 and prohibitin Asp40.
Trzeciakiewicz A; Fortin S; Moreau E; C-Gaudreault R; Lacroix J; Chambon C; Communal Y; Chezal JM; Miot-Noirault E; Bouchon B; Degoul F
Biochem Pharmacol; 2011 May; 81(9):1116-23. PubMed ID: 21371445
[TBL] [Abstract][Full Text] [Related]
10. Selective alkylation of beta(II)-tubulin and thioredoxin-1 by structurally related subsets of aryl chloroethylureas leading to either anti-microtubules or redox modulating agents.
Fortin JS; Côté MF; Lacroix J; Desjardins M; Petitclerc E; C-Gaudreault R
Bioorg Med Chem; 2008 Aug; 16(15):7277-90. PubMed ID: 18617414
[TBL] [Abstract][Full Text] [Related]
11. Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.
Legault J; Gaulin JF; Mounetou E; Bolduc S; Lacroix J; Poyet P; Gaudreault RC
Cancer Res; 2000 Feb; 60(4):985-92. PubMed ID: 10706114
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance.
Petitclerc E; Deschesnes RG; Côté MF; Marquis C; Janvier R; Lacroix J; Miot-Noirault E; Legault J; Mounetou E; Madelmont JC; C -Gaudreault R
Cancer Res; 2004 Jul; 64(13):4654-63. PubMed ID: 15231678
[TBL] [Abstract][Full Text] [Related]
13. Alkylation of beta-tubulin on Glu 198 by a microtubule disrupter.
Bouchon B; Chambon C; Mounetou E; Papon J; Miot-Noirault E; Gaudreault RC; Madelmont JC; Degoul F
Mol Pharmacol; 2005 Nov; 68(5):1415-22. PubMed ID: 16099845
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiproliferative activity evaluation and structure-activity relationships of novel aromatic urea and amide analogues of N-phenyl-N'-(2-chloroethyl)ureas.
Fortin S; Moreau E; Lacroix J; Côté MF; Petitclerc E; C-Gaudreault R
Eur J Med Chem; 2010 Jul; 45(7):2928-37. PubMed ID: 20400211
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and activity evaluation of phenylurea derivatives as potent antitumor agents.
Song DQ; Du NN; Wang YM; He WY; Jiang EZ; Cheng SX; Wang YX; Li YH; Wang YP; Li X; Jiang JD
Bioorg Med Chem; 2009 Jun; 17(11):3873-8. PubMed ID: 19410466
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents.
Li HQ; Yan T; Yang Y; Shi L; Zhou CF; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(1):305-13. PubMed ID: 19914837
[TBL] [Abstract][Full Text] [Related]
17. A new generation of N-aryl-N'-(1-alkyl-2-chloroethyl)ureas as microtubule disrupters: synthesis, antiproliferative activity, and beta-tubulin alkylation kinetics.
Mounetou E; Legault J; Lacroix J; C -Gaudreault R
J Med Chem; 2003 Nov; 46(23):5055-63. PubMed ID: 14584955
[TBL] [Abstract][Full Text] [Related]
18. Effect of an aryl chloroethyl urea on tubulin and vimentin syntheses in a human breast cancer cell line.
Poyet P; Ritchot N; Béchard P; Gaudreáult RC
Anticancer Res; 1993; 13(5A):1447-52. PubMed ID: 8239518
[TBL] [Abstract][Full Text] [Related]
19. Alkylation of prohibitin by cyclohexylphenyl-chloroethyl urea on an aspartyl residue is associated with cell cycle G(1) arrest in B16 cells.
Bouchon B; Papon J; Communal Y; Madelmont JC; Degoul F
Br J Pharmacol; 2007 Oct; 152(4):449-55. PubMed ID: 17704829
[TBL] [Abstract][Full Text] [Related]
20. New soft alkylating agents with enhanced cytotoxicity against cancer cells resistant to chemotherapeutics and hypoxia.
Patenaude A; Deschesnes RG; Rousseau JL; Petitclerc E; Lacroix J; Côté MF; C-Gaudreault R
Cancer Res; 2007 Mar; 67(5):2306-16. PubMed ID: 17332362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
